Should molnupiravir be used for covid-19 outpatient management in individuals at high risk for disease severity? A systematic review and meta-analysis of randomized controlled trials. Braz. J. Pharm. Sci. [Internet]. 5º de novembro de 2024 [citado 15º de abril de 2025];60. Disponível em: https://journals.usp.br/bjps/article/view/231188